Reta 60 mg
Retatrutide (also known as LY3437943) is an experimental triple receptor agonist targeting the glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon (GCG) receptors. This triple agonist structure has been researched for its synergistic regulation of insulin secretion, glucagon activity, and energy expenditure.
Product Specifications
| Chemical Formula |
C223H343F3N46O70 |
| Molecular Weight |
4731.34 g/mol |
| CAS Number |
2381089-83-2 |
| PubChem CID |
167606584 |
| Purity |
>99% (Guaranteed) |
| Physical State |
Lyophilized Powder (Sterile Vial) |
Key Research Applications
- Researching synergistic triple receptor agonism in metabolic regulation.
- Studying effects on insulin sensitivity, lipid profiles, and fatty acid oxidation.
- Investigating impacts on gastric emptying rate and satiety pathways.
- Exploring mechanisms of adipose tissue breakdown and weight regulation.
Reconstitution & Reagent Handling
Reconstitute with sterile bacteriostatic water. Slowly inject the diluent along the side of the vial, then gently swirl to dissolve. Avoid shaking.
Storage & Stability
Lyophilized powder should be stored at ≤8°C (ideally -20°C for long-term storage). Once reconstituted, store at 2°C to 8°C and use within 28 days.
RESEARCH USE ONLY: This product is a high-purity laboratory chemical. It is synthesized and supplied strictly for laboratory research, in vitro studies, and experimental use. This product is not approved for human or veterinary use, diagnostic procedures, or therapeutic administration.